Home Stocks ASX IMU:IMUGENE LIMITED
Listed Company

Imugene Limited (ASX IMU)

Followers 143
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

popular wires mentioning IMU

The Match Out: ASX extends rally, MA Financial suffers on visa changes, Atlas hoping for Chicago asset

The Match Out: ASX extends rally, MA Financial suffers on visa changes, Atlas hoping for Chicago asset

Equities started this week where it left off, with buyers in full control for the Monday session. Supported by strength in commodity markets and a strong US session on Friday night, the ASX managed a 1% rally today. Materials were the standout sector with rumours of Chinese stimulus helping...

Market Matters
Bell Potter reporting season calendar August 2022

Bell Potter reporting season calendar August 2022

As the August 2022 reporting season gets into full swing, we've compiled a calendar featuring ~200 ASX-listed companies, highlighting reporting dates, NPAT (consensus and Bell Potter estimates) and analyst recommendations.You can access the full report by clicking the attachment below.

Stockbroker
The Match Out: Market edges higher, Oz Minerals (OZL) up 35% as BHP makes a move

The Match Out: Market edges higher, Oz Minerals (OZL) up 35% as BHP makes a move

The market continues to show resilience with any selling at the index level met with reasonable buying aided by corporate activity from BHP towards Oz Minerals (OZL) i.e. when the world’s largest resource company is happy to outlay $8.2bn in an all-cash tilt for another Copper miner, it implies...

Market Matters
28% of ASX 300 stocks are loss makers: Here's why Macquarie is still backing 15 of them

28% of ASX 300 stocks are loss makers: Here's why Macquarie is still backing 15 of them

Off the back of the August reporting season, Macquarie has found that 28% of the S&P/ASX 300 are loss-making businesses. But you shouldn't necessarily avoid all of these stocks.  In fact, this is below the historical standard. On average since 1995, 32% of the benchmark has been loss-making, while...

Livewire Markets

Watch

Buy Hold Sell: 4 winning small caps and the worst of FY21

Livewire Markets

Latest on IMUGENE LIMITED

Equities

28% of ASX 300 stocks are loss makers: Here's why Macquarie is still backing 15 of them

Off the back of the August reporting season, Macquarie has found that 28% of the S&P/ASX 300 are loss-making businesses. But you shouldn't necessarily avoid all of...
360
+27
Ally Selby
Livewire Markets
Equities

The Match Out: ASX extends rally, MA Financial suffers on visa changes, Atlas hoping for Chicago asset

Equities started this week where it left off, with buyers in full control for the Monday session. Supported by strength in commodity markets and a strong US session...
ALX
IMU
+1
James Gerrish
Market Matters
Daily Report

The Match Out: Market edges higher, Oz Minerals (OZL) up 35% as BHP makes a move

The market continues to show resilience with any selling at the index level met with reasonable buying aided by corporate activity from BHP towards Oz Minerals (OZL)...
IMU
+4
James Gerrish
Market Matters
Equities

Bell Potter reporting season calendar August 2022

As the August 2022 reporting season gets into full swing, we've compiled a calendar featuring ~200 ASX-listed companies, highlighting reporting dates, NPAT (consensus...
29M
360
4DX
+210
Bell Potter
Stockbroker
Daily Report

The Match Out: Market rallies, broad-based buying, Metcash (MTS) delivers strong result

A solid start to the week with the ASX putting on nearly 2% led by the financial sector, although it was green right across the screen with all sectors finishing up...
IMU
+4
James Gerrish
Market Matters

Covering Imugene Limited

Bell Potter
Stockbroker
Livewire Exclusive
Livewire Markets
James Gerrish
Market Matters
Buy Hold Sell
Livewire Markets
Claire Aitchison
Independent Investment Research
Angus Kennedy
Livewire Markets

Imugene Limited (ASX:IMU) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is IMU. Livewire Markets has 10 experts who have published 13 articles that have featured Imugene Limited. You can view all those wires here. The last time time IMU was featured was on the 17 October 2022 by Ally Selby in the wire “28% of ASX 300 stocks are loss makers: Here's why Macquarie is still backing 15 of them”.